APSR2026-487

 
Late-Breaking
Submitted
Poster Presentation
 
AP14-048
P67
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1219267-46904-revAP14-048_Fasya_Afatinib_APSR2026_FINAL_435218.pdf
Format: PDF Only
08. Lung Cancer
3

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Fasya Ghaffar * Faculty of Medicine and Health Science, Lambung Mangkurat University/Ulin Hospital Banjarmasin Department of Pulmonology and Respiratory Medicine Banjarmasin Indonesia
Isa Ansori - Faculty of Medicine and Health Science, Lambung Mangkurat University/Ulin Hospital Banjarmasin Department of Pulmonology and Respiratory Medicine Banjarmasin Indonesia
Erna Kusumawardhani - Faculty of Medicine and Health Science, Lambung Mangkurat University/Ulin Hospital Banjarmasin Department of Pulmonology and Respiratory Medicine Banjarmasin Indonesia
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Fasya
Ghaffar
fasyaghaffar@gmail.com
+6281383167586
Under 30
Indonesia
Case Report
Superiority of afatinib response in EGFR exon 19 deletion versus L858R: a case series with occupational and domestic pollutant exposure
Maximum 25 words
Abstract Content
 
 
 
 
In South Kalimantan, unique environmental challenges such as recurrent biomass smoke from land and forest fires—including peat-affected areas—coupled with widespread occupational and ambient exposure to respirable crystalline silica and coal dust from the province’s intensive coal mining industry, provide a critical real-world backdrop for evaluating TKI responses in advanced EGFR-mutated NSCLC. These local pollutants, documented to drive the same core mechanisms of chronic inflammation, oxidative stress, and DNA damage, may differentially influence disease aggressiveness and afatinib response duration between exon 19 deletion and L858R mutations.
Four patients with stage IV EGFR-mutated NSCLC in South Kalimantan received first-line afatinib, all with significant occupational and/or domestic pollutant exposure. In the Del19 group (n=2), both achieved initial partial response but progressed rapidly. Case 1 (silica and coal dust) had a PFS of 22 months, whereas Case 2 (biomass smoke rich in PAH and benzene) had a PFS of only 8 months. Both L858R patients showed more durable responses (PFS 6+ and 10 months). The shorter PFS in the Del19 patient exposed to biomass smoke may result from differential pollutant effects. PAH strongly activates the AhR pathway, accelerating oxidative stress, NF-κB/MAPK signaling, and resistance bypass mechanisms in Del19 tumors, whereas crystalline silica induces slower ROS production via NLRP3 inflammasome, resulting in longer PFS.
Although exposures converge on common inflammatory-oxidative pathways, EGFR mutation subtype remains the dominant determinant of afatinib sensitivity, while environmental exposure acts as a secondary modulator of resistance. Silica appears to delay resistance in Del19, whereas PAH from biomass smoke induces rapid systemic genotoxic damage through AhR activation, CYP1A1/CYP1B1 upregulation, and DNA adduct formation, thereby accelerating resistance in Del19 tumors. These real-world findings support precision stratification by mutation subtype and exposure history in high-pollution settings. Larger studies are warranted.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Afatinib, EGFR mutation, Non-small cell lung cancer
maximum 3 keywords and no abbreviations, separated by commas
The authors declare no conflicts of interest. No financial support was received for this study. We thank the patients and their families for consenting to participate in this case series.
294